Medicinale - Diverse

  • Autor subiect Autor subiect boti
  • Dată creare Dată creare
  • Răspunsuri Răspunsuri 66
  • Vizualizări Vizualizări 3K
This is the reality most of the time. It’s about making money. Putting people on pills=drugs. Changing who they are by turning them into obedient robots.

 

 
the comments are so funny....I did the test. Guess my death is also imminent. Which only sucks because - who is gonna keep the forum alive?

 





1. Eleanor Chen, 63, pharmacist since 1979, retired early after testifying against Pfizer. Her first revelation: Magnesium threonate. "Only form that reaches the brain. We've known since 2010 it reverses cognitive decline markers. Supplement industry buries it — profit margin is 90% lower than multivitamins." After 40, you don't lose energy first. You lose mental continuity. She said doctors know but prescribing it means losing pharma kickbacks. Follow — tomorrow I reveal the 2010 study they tried erasing.

2. K2 (MK-7), not calcium. Eleanor's court testimony: "We created the osteoporosis epidemic by pushing isolated calcium. It calcifies arteries while bones stay porous." Pharmacists privately call it "the profitable poison." K2 redirects calcium to bones, away from vessels. Costs $9/month. Calcium supplements generate $4B yearly. She said one pharma VP told her: "K2 would collapse the calcium market overnight."

3. Glycine before sleep. Not advertised because it costs pennies. "Ambien makes $2B yearly. Glycine does the same job for $15 annually." She used sleep trackers on herself: 52% increase in deep sleep within 3 weeks. Lowers core temperature, rebuilds architecture. Pharma funded studies to discredit it. Failed. Buried the data anyway.

4. Ubiquinol, not CoQ10. After 35, enzyme conversion fails. "Every pharmacist over 40 I know takes ubiquinol. We stock CoQ10 because markup is 800%." She quit after being ordered to remove ubiquinol from shelves "due to low demand." Demand wasn't low. Margin was.

5. Boron. Nearly extinct from supplements. "Trace minerals don't patent well. No patents, no pharma investment, no marketing, no sales." She showed me a 1987 study: boron increased free testosterone 28% in men, improved bone density 11% in women. Never replicated. Not because it failed — because it worked too cheaply.
 
Back
Sus